{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:11:08Z","timestamp":1760044268737},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,8,5]],"date-time":"2012-08-05T00:00:00Z","timestamp":1344124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00277-012-1531-1","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T10:30:52Z","timestamp":1344076252000},"page":"1917-1922","source":"Crossref","is-referenced-by-count":18,"title":["A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience"],"prefix":"10.1007","volume":"91","author":[{"given":"Sun-Joo","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dok Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinkyo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dal Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Sook","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheolwon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,5]]},"reference":[{"key":"1531_CR1","first-page":"262","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"L Leoncini","year":"2008","unstructured":"Leoncini L et al (2008) Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 262\u2013264","edition":"4"},{"key":"1531_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS et al (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood 107:265\u2013276","journal-title":"Blood"},{"key":"1531_CR3","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009\u20133020","journal-title":"Blood"},{"key":"1531_CR4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"I Magrath","year":"1996","unstructured":"Magrath I, Adde M, Shad A et al (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925\u2013934","journal-title":"J Clin Oncol"},{"key":"1531_CR5","first-page":"337","volume":"6","author":"DH Wright","year":"1971","unstructured":"Wright DH (1971) Burkitt\u2019s lymphoma: a review of the pathology, immunology, and possible etiologic factors. Pathol Annu 6:337\u2013363","journal-title":"Pathol Annu"},{"key":"1531_CR6","first-page":"119","volume":"60","author":"IT Magrath","year":"1985","unstructured":"Magrath IT, Sariban E (1985) Clinical features of Burkitt\u2019s lymphoma in the USA. IARC Sci Publ 60:119\u2013127","journal-title":"IARC Sci Publ"},{"key":"1531_CR7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J et al (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13:1264\u20131274","journal-title":"Ann Oncol"},{"key":"1531_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1991.9.6.941","volume":"9","author":"ML McMaster","year":"1991","unstructured":"McMaster ML, Greer JP, Greco FA et al (1991) Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol 9:941\u2013946","journal-title":"J Clin Oncol"},{"key":"1531_CR9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M et al (1995) Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664\u2013674","journal-title":"Blood"},{"key":"1531_CR10","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3109\/10428194.2011.593274","volume":"52","author":"T Wasterlid","year":"2011","unstructured":"Wasterlid T, Jonsson B, Hagberg H, Jerkeman M (2011) Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study. Leuk Lymphoma 52:2090\u20132096","journal-title":"Leuk Lymphoma"},{"key":"1531_CR11","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J et al (2001) The Societe Francaise d\u2019Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97:3370\u20133379","journal-title":"Blood"},{"key":"1531_CR12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1080\/10428190701882948","volume":"49","author":"TC Kian","year":"2008","unstructured":"Kian TC, Miriam T, Richard Q et al (2008) Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians. Leuk Lymphoma 49:824\u2013827","journal-title":"Leuk Lymphoma"},{"key":"1531_CR13","doi-asserted-by":"crossref","unstructured":"(1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 329:987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"key":"1531_CR14","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K et al (1971) Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"1531_CR15","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332\u2013339","journal-title":"Semin Oncol"},{"key":"1531_CR16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"1531_CR17","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, Petroni GR, Schiffer CA et al (2001) Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol 19:4014\u20134022","journal-title":"J Clin Oncol"},{"key":"1531_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM199710303371802","volume":"337","author":"MP Link","year":"1997","unstructured":"Link MP, Shuster JJ, Donaldson SS et al (1997) Treatment of children and young adults with early-stage non-Hodgkin\u2019s lymphoma. N Engl J Med 337:1259\u20131266","journal-title":"N Engl J Med"},{"key":"1531_CR19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1200\/JCO.1993.11.5.943","volume":"11","author":"TM Waits","year":"1993","unstructured":"Waits TM, Greco FA, Greer JP et al (1993) Effective therapy for poor-prognosis non-Hodgkin\u2019s lymphoma with 8 weeks of high-dose-intensity combination chemotherapy. J Clin Oncol 11:943\u2013949","journal-title":"J Clin Oncol"},{"key":"1531_CR20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","volume":"12","author":"WS Velasquez","year":"1994","unstructured":"Velasquez WS, McLaughlin P, Tucker S et al (1994) ESHAP\u2014an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12:1169\u20131176","journal-title":"J Clin Oncol"},{"key":"1531_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"1531_CR22","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O\u2019Brien S et al (1999) Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol 17:2461\u20132470","journal-title":"J Clin Oncol"},{"key":"1531_CR23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.6004\/jnccn.2010.0021","volume":"8","author":"AD Zelenetz","year":"2010","unstructured":"Zelenetz AD, Abramson JS, Advani RH et al (2010) NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin\u2019s lymphomas. J Natl Compr Canc Netw 8:288\u2013334","journal-title":"J Natl Compr Canc Netw"},{"key":"1531_CR24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00277-009-0729-3","volume":"88","author":"MK Choi","year":"2009","unstructured":"Choi MK, Jun HJ, Lee SY et al (2009) Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol 88:1099\u20131106","journal-title":"Ann Hematol"},{"key":"1531_CR25","doi-asserted-by":"crossref","unstructured":"Pohlen M, Gerth HU, Liersch R et al. (2011) Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL\/NHL 2002 protocol) in Burkitt\u2019s and primary mediastinal large B-cell lymphoma. Am J Hematol 86(12):E61\u2013E64","DOI":"10.1002\/ajh.22165"},{"key":"1531_CR26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","volume":"106","author":"DA Thomas","year":"2006","unstructured":"Thomas DA, Faderl S, O\u2019Brien S et al (2006) Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 106:1569\u20131580","journal-title":"Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1531-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1531-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1531-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T08:55:44Z","timestamp":1594544144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1531-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,5]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1531-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,5]]}}}